Loading
Techcyte
Techcyte is a healthcare technology company based in Orem, Utah, founded in 2013. It specializes in developing an AI platform for anatomic and clinical pathology, aimed at digitizing lab workflows and enhancing diagnostic accuracy. The company employs around 155 people and has secured over $36 million in funding from notable investors, including ARUP Laboratories and the University of Utah. The flagship product, Techcyte Fusion™, is a cloud-native digital pathology platform that integrates whole slide imaging, lab information systems, electronic health records, and AI tools. This platform supports various diagnostic tests across histology, hematology, cytology, bacteriology, and parasitology. Techcyte also offers specialized AI suites for cervical cytology, frozen section analysis, parasitology, and bacteriology. The company serves clinical labs, pathology clinics, research institutions, and hospital systems, and has established partnerships with whole slide scanner manufacturers and AI vendors. Techcyte's mission is to improve lab efficiency and transform healthcare globally through AI technology.
Funding
Every round, secondary, debt facility or acquisition involving Techcyte that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
$20M